ALLISON BLAKE: Open Payments
NPI 1295213684 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,781 in 77 payments from 14 companies in 2025. Trend: 2023 $1,060 · 2024 $2,188 · 2025 $1,781
Food & beverage: $1,781
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $485 |
| Vanda Pharmaceuticals Inc. | 7 | $252 |
| Otsuka America Pharmaceutical, Inc. | 10 | $176 |
| Lundbeck LLC | 7 | $169 |
| E.R. Squibb & Sons, L.L.C. | 5 | $162 |
| Neurocrine BioSciences, Inc. | 6 | $120 |
| Alkermes, Inc. | 6 | $110 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| Supernus Pharmaceuticals, Inc. | 3 | $71 |
| Axsome Therapeutics, Inc. | 2 | $51 |
Products named: VRAYLAR, REXULTI, FANAPT, COBENFY, INGREZZA, SPRAVATO, ARISTADA, Qelbree.
Industry payments across NY — which companies pay providers there.
